醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
URGN · UroGen Pharma Ltd.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
UroGen Pharma Ltd.（URGN）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $3.4M；高管董事有效買入 —、有效賣出 $2.9M。最近申報 2026-10-09。
買入 Bought—
賣出 Sold$3.4M
有效買入 Effective bought—
有效賣出 Effective sold$2.9M
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-08 | Degnan Chris Chief Financial Officer | 賣出 Sell | 2,202 | $36.69 | $81K | SEC |
| 2026-09-08 | Schoenberg Mark Chief Medical Officer | 賣出 Sell | 871 | $42.92 | $37K | SEC |
| 2026-09-08 | Smith Jason Drew General Counsel | 賣出 Sell | 1,519 | $42.54 | $65K | SEC |
| 2026-08-20 | Schoenberg Mark Chief Medical Officer | 賣出 Sell · 有效 | 60,677 | $47.05 | $2.9M | SEC |
| 2026-07-09 | Schoenberg Mark Chief Medical Officer | 賣出 Sell | 10,000 | $40.00 | $400K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-08 | Degnan Chris Officer | 2,202 | $90K | |
| 2026-09-08 | Smith Jason Drew Officer | 1,519 | $67K | |
| 2026-09-08 | Schoenberg Mark Officer | 871 | $38K | |
| 2026-08-20 | Schoenberg Mark Officer | 60,677 | $2.9M | |
| 2026-07-09 | Schoenberg Mark Officer | 10,000 | $400K | 10b5-1 |
內部人 Insiders
Degnan Chris、Schoenberg Mark、Smith Jason Drew